Oral idarubicin as a palliative agent in leukemia.
Davis
C L
CL
IRCF Department of Medical Oncology, St Bartholomew's Hospital, London, U.K.
Rohatiner
A Z
AZ
Amess
J A
JA
Lister
T A
TA
D000284:Administration, Oral; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy*; D010166:Palliative Care
D015255:Idarubicin